These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28438082)
1. Radioimmunoconjugates for treating cancer: recent advances and current opportunities. Bourgeois M; Bailly C; Frindel M; Guerard F; Chérel M; Faivre-Chauvet A; Kraeber-Bodéré F; Bodet-Milin C Expert Opin Biol Ther; 2017 Jul; 17(7):813-819. PubMed ID: 28438082 [TBL] [Abstract][Full Text] [Related]
2. New insights into the pretargeting approach to image and treat tumours. Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526 [TBL] [Abstract][Full Text] [Related]
3. [Radiolabeled antibodies for cancer treatment]. Barbet J; Chatal JF; Kraeber-Bodéré F Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676 [TBL] [Abstract][Full Text] [Related]
10. Engineered Antibodies as Cancer Radiotheranostics. Wei Z; Li B; Wen X; Jakobsson V; Liu P; Chen X; Zhang J Adv Sci (Weinh); 2024 Aug; 11(30):e2402361. PubMed ID: 38874523 [TBL] [Abstract][Full Text] [Related]
11. Macromolecular approach for targeted radioimmunotherapy in non-Hodgkin's lymphoma. Hee C; Ho D; Karton A; Nealon G; Kretzmann JA; Norret M; Iyer KS Chem Commun (Camb); 2019 Nov; 55(96):14506-14509. PubMed ID: 31735949 [TBL] [Abstract][Full Text] [Related]
12. Targeted cancer therapy using radiolabeled monoclonal antibodies. Bethge WA; Sandmaier BM Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058 [TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents. Pauwels EK; Erba P Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631 [TBL] [Abstract][Full Text] [Related]
14. Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors--a review of radiolabeling characteristics, quality control and in vitro stability studies. Iznaga-Escobar N Appl Radiat Isot; 2001 Mar; 54(3):399-406. PubMed ID: 11214873 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies. Kawashima H ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy for cancer. von Mehren M; Adams GP; Weiner LM Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678 [TBL] [Abstract][Full Text] [Related]
17. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model. Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949 [TBL] [Abstract][Full Text] [Related]
18. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates. Quadri SM; Vriesendorp HM Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840 [TBL] [Abstract][Full Text] [Related]
19. The use of radioimmunoconjugates in stem cell transplantation. Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer. Fleckenstein G; Osmers R; Puchta J Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]